BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15721383)

  • 1. Liposome-mediated suicide gene therapy in humans.
    Reszka RC; Jacobs A; Voges J
    Methods Enzymol; 2005; 391():200-8. PubMed ID: 15721383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma.
    Voges J; Reszka R; Gossmann A; Dittmar C; Richter R; Garlip G; Kracht L; Coenen HH; Sturm V; Wienhard K; Heiss WD; Jacobs AH
    Ann Neurol; 2003 Oct; 54(4):479-87. PubMed ID: 14520660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J; Liu TJ; Lu Y
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.
    Floeth FW; Shand N; Bojar H; Prisack HB; Felsberg J; Neuen-Jacob E; Aulich A; Burger KJ; Bock WJ; Weber F
    Cancer Gene Ther; 2001 Nov; 8(11):843-51. PubMed ID: 11773974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.
    Colombo F; Barzon L; Franchin E; Pacenti M; Pinna V; Danieli D; Zanusso M; Palù G
    Cancer Gene Ther; 2005 Oct; 12(10):835-48. PubMed ID: 15891772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
    Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
    Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of polyethylenimine-mediated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3].
    Jin P; Kong BH
    Ai Zheng; 2005 Jul; 24(7):806-11. PubMed ID: 16004805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells.
    Ammerpohl O; Thormeyer D; Khan Z; Appelskog IB; Gojkovic Z; Almqvist PM; Ekström TJ
    Biochem Biophys Res Commun; 2004 Nov; 324(1):8-14. PubMed ID: 15464975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.
    Konopka K; Fallah B; Monzon-Duller J; Overlid N; Düzgünes N
    Cell Mol Biol Lett; 2005; 10(3):455-70. PubMed ID: 16217556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
    Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
    Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
    Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
    Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.